First Trust Advisors LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

First Trust Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $1.2 Million - $2.11 Million	-14,436 Reduced 35.02%	26,784 $3.9 Million
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $1.47 Million - $1.91 Million	-13,385 Reduced 24.51%	41,220 $4.89 Million
Q4 2021 Feb 08, 2022	SELL	$99.73 - $148.48 $3.75 Million - $5.59 Million	-37,642 Reduced 40.81%	54,605 $7.53 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $5.8 Million - $8.15 Million	58,707 Added 175.04%	92,247 $12.8 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $2.21 Million - $3.52 Million	33,540 New	33,540 $3.26 Million
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $3 Million - $4.3 Million	-46,827 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$65.07 - $98.24 $628,966 - $949,587	-9,666 Reduced 17.11%	46,827 $4.01 Million
Q3 2020 Nov 05, 2020	BUY	$59.04 - $77.95 $274,417 - $362,311	4,648 Added 8.97%	56,493 $3.67 Million
Q2 2020 Jul 22, 2020	BUY	$29.01 - $74.23 $1.5 Million - $3.85 Million	51,845 New	51,845 $3.79 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.